175 related articles for article (PubMed ID: 38732135)
21. Evaluation of Elastin-Like Polypeptides for Tumor Targeted Delivery of Doxorubicin to Glioblastoma.
Dragojevic S; Mackey R; Raucher D
Molecules; 2019 Sep; 24(18):. PubMed ID: 31489879
[TBL] [Abstract][Full Text] [Related]
22. Antimetastatic activities of synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) peptide analogues and their inhibitory mechanisms.
Fujii H; Komazawa H; Mori H; Kojima M; Itoh I; Murata J; Azuma I; Saiki I
Biol Pharm Bull; 1995 Dec; 18(12):1681-8. PubMed ID: 8787788
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells.
Shannon S; Vaca C; Jia D; Entersz I; Schaer A; Carcione J; Weaver M; Avidar Y; Pettit R; Nair M; Khan A; Foty RA
PLoS One; 2015; 10(8):e0135951. PubMed ID: 26284619
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells.
Hayward SL; Wilson CL; Kidambi S
Oncotarget; 2016 Jun; 7(23):34158-71. PubMed ID: 27120809
[TBL] [Abstract][Full Text] [Related]
25. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
Shi D; Mi G; Shen Y; Webster TJ
Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
[TBL] [Abstract][Full Text] [Related]
26. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
27. Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent.
Haas B; Ciftcioglu J; Jermar S; Weickhardt S; Eckstein N; Kaina B
J Cancer Res Clin Oncol; 2021 Mar; 147(3):779-792. PubMed ID: 33315125
[TBL] [Abstract][Full Text] [Related]
28. Dual-functional supramolecular nanohybrids of quantum dot/biopolymer/chemotherapeutic drug for bioimaging and killing brain cancer cells in vitro.
Mansur AAP; Caires AJ; Carvalho SM; Capanema NSV; Carvalho IC; Mansur HS
Colloids Surf B Biointerfaces; 2019 Dec; 184():110507. PubMed ID: 31542643
[TBL] [Abstract][Full Text] [Related]
29. Hydrogel matrix presence and composition influence drug responses of encapsulated glioblastoma spheroids.
Hill L; Bruns J; Zustiak SP
Acta Biomater; 2021 Sep; 132():437-447. PubMed ID: 34010694
[TBL] [Abstract][Full Text] [Related]
30. Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel.
Ngo MT; Harley BAC
Biomaterials; 2019 Apr; 198():122-134. PubMed ID: 29941152
[TBL] [Abstract][Full Text] [Related]
31. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
32. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
[TBL] [Abstract][Full Text] [Related]
33. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier.
Kostka K; Sokolova V; El-Taibany A; Kruse B; Porada D; Wolff N; Prymak O; Seeds MC; Epple M; Atala AJ
Molecules; 2024 May; 29(11):. PubMed ID: 38893345
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia activates enhanced invasive potential and endogenous hyaluronic acid production by glioblastoma cells.
Chen JE; Lumibao J; Blazek A; Gaskins HR; Harley B
Biomater Sci; 2018 Mar; 6(4):854-862. PubMed ID: 29485655
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin.
Yang CH; Wang Y; Sims M; Cai C; Pfeffer LM
Cancer Lett; 2019 Nov; 465():59-67. PubMed ID: 31491450
[TBL] [Abstract][Full Text] [Related]
36. Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma.
Majumder P; Baxa U; Walsh STR; Schneider JP
Angew Chem Int Ed Engl; 2018 Nov; 57(46):15040-15044. PubMed ID: 30240496
[TBL] [Abstract][Full Text] [Related]
37. Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels.
Gojgini S; Tokatlian T; Segura T
Mol Pharm; 2011 Oct; 8(5):1582-91. PubMed ID: 21823632
[TBL] [Abstract][Full Text] [Related]
38. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma.
Karavasili C; Panteris E; Vizirianakis IS; Koutsopoulos S; Fatouros DG
Pharm Res; 2018 Jun; 35(8):166. PubMed ID: 29943122
[TBL] [Abstract][Full Text] [Related]
40. Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB.
Tchoghandjian A; Jennewein C; Eckhardt I; Momma S; Figarella-Branger D; Fulda S
Cell Death Differ; 2014 May; 21(5):735-47. PubMed ID: 24488095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
